Рубрика
Blog
-
2023
-
Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in adults on dialysis
-
MHRA Approves Nubeqa Treatment Combination for Advanced Form of Prostate Cancer
-
NICE Recommends Epidyolex for Tuberous Sclerosis Complex Seizures
-
API Distributor LGM Pharma Enters Consent Decree
-
FDA Approves Sutimlimab-jome with Long-Term Safety, Efficacy Data for Cold Agglutinin Disease
-
EU Expands Dupixent’s Authorization for Eosinophilic Esophagitis
-
Roche, Boehringer tap biosensor firms for patient studies
-
FDA Grants Accelerated Approval to Eli Lilly’s Jaypirca in Mantle Cell Lymphoma
-
FDA Approves Stemline’s Orserdu for Several Forms of Breast Cancer
-
Cassava Claims Phase 2 Win for Its Alzheimer’s Candidate